Journal
HEPATOLOGY RESEARCH
Volume 44, Issue 10, Pages E304-E308Publisher
WILEY
DOI: 10.1111/hepr.12262
Keywords
benign recurrent intrahepatic cholestasis; cholestasis; jaundice; Prometheus; pruritus
Categories
Funding
- Ministry of Health, Czech Republic - conceptual development of research organizations (Institute for Clinical and Experimental Medicine - IKEM) [IN 00023001]
Ask authors/readers for more resources
Benign recurrent intrahepatic cholestasis (BRIC) is an autosomal recessive liver disorder characterized by recurrent episodes of jaundice and itching. Episodes of cholestasis last variously from 1 week to several months, may start at any age and usually resolve spontaneously. No effective treatment has been found as yet. We report a case of genetically proven BRIC in a male patient who developed three episodes of pruritus and jaundice at the age of 14, 16 and 19 years. During the third episode, he did not respond to pharmacological medical therapy, and fractionated plasma separation and absorption (FPSA, Prometheus) was performed to manage intractable pruritus. The treatment immediately alleviated pruritus, lowered serum bilirubin concentration and induced sustained remission in the 5-year follow up. FPSA seems to be a safe and effective way of treatment for BRIC in patients with severe pruritus and prolonged jaundice.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available